首页> 外文OA文献 >The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small cell lung cancer (SCLC) receiving platinum-based chemotherapy: evidence from meta-analysis.

【2h】

The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small cell lung cancer (SCLC) receiving platinum-based chemotherapy: evidence from meta-analysis.

机译：切除修复交叉互补组1（ERCC1）对接受铂类化疗的小细胞肺癌（sCLC）患者的预后价值：来自荟萃分析的证据。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yanlong Yang; Xiuping Luo; Nuo Yang; Ronghao Feng; Lei Xian;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy [J] . Adel Gabr, T. M. Elsaba, Khalid Razek, Journal of Cancer Therapy . 2016 ,第9期

机译：切除修复交叉互补组1（ERCC1）：接受基于奥沙利铂辅助化疗的大肠癌患者的预后和预测性生物标志物
2. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis [J] . Bisof Vesna, Petranovic Matea Zajc, Rakusic Zoran, European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) . 2016 ,第9期

机译：铂类疗法治疗的1288例头颈部鳞状细胞癌患者中切除修复交叉互补1族（ERCC1）蛋白的预后和预测价值：一项荟萃分析
3. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature. [J] . Vilmar A, Sorensen JB Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2009 ,第2期

机译：切除修复交叉互补组1（ERCC1）在以铂为基础的非小细胞肺癌治疗中，尤其以卡铂为重点：近期文献综述。
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis [O] . Yanlong Yang, Xiuping Luo, Nuo Yang, -1

机译：切除修复交叉互补组1（ERCC1）对接受铂类化学疗法的小细胞肺癌（SCLC）患者的预后价值：来自荟萃分析的证据
7. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis. [O] . Bišof Vesna, Zajc Petranović Matea, Rakušić Zoran, 2016

机译：切除修复交叉互补组1（ERCC1）蛋白在1288例接受铂类治疗的头颈部鳞状细胞癌患者中的预后和预测价值：荟萃分析。

The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small cell lung cancer (SCLC) receiving platinum-based chemotherapy: evidence from meta-analysis.

著录项

相似文献

相关主题

期刊订阅